How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Biopharmaceutical Third Party Logistics (3PL) Market
- By Service Type: Cold Chain Logistics, Warehousing and Distribution, Transportation Management, Inventory Management, Packaging and Labeling
- By Mode of Transportation: Air Freight, Road Freight, Sea Freight, Rail Freight
- By End User: Pharmaceutical Manufacturers, Biotechnology Companies, Contract Research Organizations (CROs), Hospitals and Healthcare Providers, Clinical Trial Sponsors
- By Temperature Range: Frozen (-20°C and below), Refrigerated (2°C to 8°C), Controlled Room Temperature (15°C to 25°C)
- By Service Provider Type: Third-Party Logistics Providers, Specialized Cold Chain Logistics Providers, Integrated Logistics Providers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Cold Chain Logistics leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Biopharmaceutical Third Party Logistics (3PL) Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Service Type 5
Mode of Transportation 4
End User 5
Temperature Range 3
Service Provider Type 3
Companies profiled
DHL Supply Chain
Kuehne + Nagel
UPS Healthcare
FedEx Supply Chain
DB Schenker
Ceva Logistics
XPO Logistics
Panalpina (now part of DSV)
GEODIS
Agility Logistics
Hellmann Worldwide Logistics
Bolloré Logistics
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →DHL Supply Chain
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Kuehne + Nagel
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →UPS Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →FedEx Supply Chain
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →DB Schenker
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Ceva Logistics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →XPO Logistics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Panalpina (now part of DSV)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →GEODIS
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Agility Logistics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Hellmann Worldwide Logistics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Bolloré Logistics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Expeditors International
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Yusen Logistics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Sinotrans
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$11,676M by 2033 · 9.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Cold Chain Logistics57.6
- Warehousing and Distribution13.3
- Transportation Management10.7
- Inventory Management10.5
- Packaging and Labeling7.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,824M → $3,552M · 8.7%
Europe$1,271M → $2,480M · 8.7%
Asia Pacific$1,161M → $2,709M · 11.2%
Latin America$718.5M → $1,488M · 9.5%
Middle East and Africa$552.7M → $1,189M · 10.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.742026
9.762027
9.782028
9.802029
9.812030
9.812031
9.822032
9.832033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- DHL Supply Chain21.2
- Kuehne + Nagel17.3
- UPS Healthcare6.8
- FedEx Supply Chain4.8
- DB Schenker12.3
- Ceva Logistics9.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type16.5%
Mode of Transportation12.3%
End User10.7%
Temperature Range28.5%
Service Provider Type31.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.1
- Europe21.7
- Asia Pacific23.7
- Latin America13.0
- Middle East and Africa10.4
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| DHL Supply Chain | 98 | 93 | 77 | 88 | 78 | 99 | 89 |
| Kuehne + Nagel | 93 | 84 | 73 | 87 | 82 | 70 | 82 |
| UPS Healthcare | 62 | 70 | 66 | 81 | 69 | 86 | 72 |
| FedEx Supply Chain | 59 | 75 | 81 | 76 | 65 | 81 | 73 |
| DB Schenker | 66 | 65 | 60 | 72 | 68 | 68 | 67 |
| Ceva Logistics | 56 | 71 | 63 | 67 | 52 | 47 | 59 |
| XPO Logistics | 55 | 49 | 55 | 50 | 64 | 60 | 56 |
| Panalpina (now part of DSV) | 50 | 36 | 58 | 47 | 54 | 42 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- DHL Supply Chain
- Kuehne + Nagel
- UPS Healthcare
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| DHL Supply Chain | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Kuehne + Nagel | ✓ | ✓ | − | ◐ | ✓ | ◐ |
| UPS Healthcare | − | ◐ | ◐ | ✓ | ◐ | ✓ |
| FedEx Supply Chain | − | − | ✓ | ◐ | ◐ | ✓ |
| DB Schenker | ◐ | ◐ | − | − | ◐ | − |
| Ceva Logistics | ◐ | ◐ | ◐ | ✓ | ◐ | − |
| XPO Logistics | ◐ | − | ◐ | − | − | ◐ |
| Panalpina (now part of DSV) | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1DHL Supply Chain89
2Kuehne + Nagel82
3FedEx Supply Chain73
4UPS Healthcare72
5DB Schenker67
6Ceva Logistics59
7XPO Logistics56
8Panalpina (now part of DSV)48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
DHL Supply ChainKuehne + Nagel
Challenger3
Strong scale, closing on the leaders.
UPS HealthcareFedEx Supply ChainDB Schenker
Contender1
Focused players with pockets of strength.
Ceva Logistics
Niche2
Specialists in a single segment or region.
XPO LogisticsPanalpina (now part of DSV)
Go-to-market strategy
Land Service Type in North America, then scale across Biopharmaceutical Third Party Logistics (3PL) Market — a $695M beachhead inside a $11.5B market.
Beachhead (SOM)$695Mobtainable near-term
Serviceable (SAM)$4.38Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Cold Chain Logistics
Best fit — highest urgency & budget in Service Type.
Economic buyer76 fit
Warehousing and Distribution
Strong fit — clear ROI and a fast path to value.
End user65 fit
Transportation Management
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Mode of Transportation & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales48%
Partner / channel28%
Digital / self-serve19%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Biopharmaceutical Third Party Logistics (3PL) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified22%
Evaluation12%
Closed-won8%
$15.7KCAC
$70KLTV
4.5:1LTV : CAC
< 4 moCAC payback
Investment thesis
Biopharmaceutical Third Party Logistics (3PL) Market is a durable-growth opportunity — $5.36B by 2033, compounding at 7.9%.
TAM · 2025$2.91Btoday
TAM · 2033$5.36Bforecast
CAGR7.9%2027–2033
Cumulative$36.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.36BTotal addressable market
SAM$2.06BServiceable available market
SOM$408MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.9% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.36BLarge & growingTAM by 2033 at 7.9% CAGR
$2.06BServiceable nowreachable with today’s model
$408MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.18BBear5.2% CAGR
$5.36BBase7.9% CAGR
$6.86BBull10.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Mode of Transportation optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Biopharmaceutical Third Party Logistics (3PL) Market — a $7.48B market by 2033. Plan: grow share from 8.2% to 14.5%.
Market size · 2033$7.48Btotal addressable
Market CAGR9.7%2027–2033
Target share14.5%from 8.2% today
Revenue ambition$1.08Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.2% | 14.5% | On track |
| Revenue | $638M | $1.08B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 35.9% | 45.5% | Ahead |
| Customer retention | 87.2% | 94.8% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Mode of Transportation capability
A defensible second engine — invest in Mode of Transportation to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Mode of Transportation
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $147M capacity & capability investment
- Greenlight bolt-on M&A in Mode of Transportation
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeAhead
- Execution & talentAt risk
Sales deck · value proposition
Win the Biopharmaceutical Third Party Logistics (3PL) Market conversation — a $725M market you can size, segment and defend in minutes.
Market size · 2033$725Mtotal opportunity
Growth6.3%CAGR to 2033
Addressable buyers1,674+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 3 mopayback period
$96K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
DHL Supply ChainKuehne + NagelUPS HealthcareFedEx Supply ChainDB SchenkerCeva LogisticsXPO LogisticsPanalpina (now part of DSV)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Biopharmaceutical Third Party Logistics (3PL) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Biopharmaceutical Third Party Logistics (3PL) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Biophilic Acoustic Product Market
Market size, share, segmentation and regional forecast.
$759M market · 2025 base year
View reportBiophotonic Imaging Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportBiophotonic Sensors Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportBio-plastic Material Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportBio-Poly Alpha Olefin (PAO) Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBio-Polyethylene Terephthalate (Bio-Pet) Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportBio-Polyethylene Terephthalate (Bio-Pet) Technology Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportBio-polylactic Acid (PLA) Film Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportBio-Polylactic Acid Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportBiopolymer Coatings Materials Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportBiopolymer Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportBiopolymer Materials Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.